Switch to
More onapp

How to use scorecard? Learn more

Alpa Laboratories Ltd

ALPA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹241 cr, stock is ranked 2,321
High RiskStock is 3.50x as volatile as Nifty
117.062.40 (+2.09%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹241 cr, stock is ranked 2,321
High RiskStock is 3.50x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
11.57
PB RatioPB Ratio
1.59
Dividend YieldDiv. Yield
Sector PESector PE
50.40
Sector PBSector PB
6.41
Sector Div YldSctr Div Yld
0.53%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Alpa Laboratories Limited is a pharmaceutical company. The Company operates in the drugs and chemicals segment.

Financial TrendFinancial statements 

2021202220232024101.95123.05102.33123.637.2414.1012.5916.78
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Board Meeting Intimation 
Announced OnFeb 3, 2025

ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business. | Download

ALPA LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 13-Feb-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Other business. | Download

Board Meeting 
Announced OnFeb 3, 2025

ALPA LABORATORIES LTD. - 532878 - Board Meeting Intimation for To Approve The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2024. | Download

ALPA LABORATORIES LTD. - 532878 - Board Meeting Intimation for To Approve The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2024. | Download

Trading Window 
Announced OnDec 30, 2024

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 | Download

See all events